Prevention of contrast-induced nephropathy in patients undergoing percutaneous coronary interventions in everyday clinical practice
Journal Title: Archives of Medical Science - Year 2006, Vol 2, Issue 4
Abstract
Introduction: Contrast nephropathy is a potentially serious complication of PCI, particularly in patients with chronic kidney disease – CKD. Material and methods: Assessment of the effects of preventive measures on the prevalence of contrast-induced nephropathy in 529 consecutive patients with coronary artery disease undergoing percutaneous coronary interventions. In all the patients 24 h before PCI all nephrotoxic drugs (NSAIDs, diuretics, biguanidine derivatives in diabetic patients) were withdrawn and doses of ACEi were either withdrawn or reduced. Results: Only 27.4-47.7% of patients with normal serum creatinine at admission had eGFR over 90 ml/min according to Cockcroft-Gault and MDRD formulae. In 39 patients we observed a rise in serum creatinine of more than 25% relative to baseline. More frequently they were females, hypertensive, PCI time was longer and contrast volume was higher. In 5 pts (0.9%) acute renal failure was observed (rise in creatinine more than 0.5 mg/dl relative to baseline). These patients received more contrast agent (p
Authors and Affiliations
Hanna Bachórzewska-Gajewska, Jolanta Małyszko, Ewa Sitniewska, Jacek Małyszko, Sławomir Dobrzycki
Keywords
Related Articles
- EP ID EP149565
- DOI -
- Views 140
- Downloads 0
Cardiovascular risk factors: lipids and lifestyle changes
Study of relationship between IL-1Ra gene polymorphism and GVHD in HLA – identical sibling allogenic transplants
Introduction: The interleukin-1 (IL-1) gene family includes three members (IL-1a, IL-1b and IL-1Ra) that mediate immune and inflammatory responses. Interleukin-1 (IL-1) is an inflammatory cytokine involved in various aut...
Highlights of the 8th Congress of the European Society for Sexual Medicine Copenhagen, December 4-7, 2005
What is new in medicine What is new in urology?
Epidural spinal cord stimulation in therapy-resistant angina pectoris – influence on myocardial perfusion or improvement of the quality of life? Pilot study